雜志介紹

Familial Cancer雜志介紹

《Familial Cancer》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱家族性癌癥，本刊主要出版、報道醫(yī)學-GENETICS & HEREDITY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.8，最新CiteScore 指數(shù)為4.1。

本刊近期中國學者發(fā)表的論文主要有：

• Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer

  Author: Shuying Li, Xiaojuan Zhao, Zhiwei Wu, Ye Li, Lin Zhu, Binbin Cui, Xinshu Dong, Suli Tian, Fulan Hu, Yashuang Zhao

• Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese

  Author: Tielong Tang, Hui Xue, Shu Cui, Zhiyong Gong, Zhonghai Fei, Shulin Cheng, Chunyan Gui

• Genetic 135G/C polymorphism of <Emphasis Type="Italic">RAD51</Emphasis> gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls

  Author: Bei-bei Zhang, Dao-gang Wang, Chao Xuan, Gui-li Sun, Kai-feng Deng

• Mitochondrial membrane potential and reactive oxygen species in cancer stem cells

  Author: Bei-bei Zhang, Dao-gang Wang, Fen-fen Guo, Chao Xuan

英文介紹

Familial Cancer雜志英文介紹

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician.

The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.